| |
|
|
|
|
The following is an excerpt from a S-1 SEC Filing, filed by TARGANTA THERAPEUTICS CORP. on 5/11/2007. |
|
|
|
|
TARGANTA THERAPEUTICS CORP. - S-1 - 20070511 - COMPENSATION_TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
|
Bonus
($)
|
|
Option
Awards
($)(1)
|
|
All Other
Compensation
($)(2)
|
|
|
Total
($)
|
|
Mark Leuchtenberger(3),
Director, Chief
Executive Officer and President
|
|
2006
|
|
$
|
100,685
|
(5)
|
|
|
—
|
|
$
|
950
|
|
$
|
541
|
(7)
|
|
$
|
102,176
|
|
|
|
|
|
|
|
|
|
Pierre Etienne(3),
Chief Development Officer
|
|
2006
|
|
$
|
278,356
|
|
|
$
|
95,000
|
|
$
|
35,461
|
|
$
|
1,732
|
(7)
|
|
$
|
410,549
|
|
|
|
|
|
|
|
|
|
George Eldridge(4),
Senior Vice President, Finance
& Administration, Treasurer
and Assistant Secretary
|
|
2006
|
|
$
|
59,068
|
(6)
|
|
|
—
|
|
$
|
282
|
|
$
|
142
|
(7)
|
|
$
|
59,492
|
|
|
|
|
|
|
|
|
|
Christian Bélisle(4),
Vice President,
Finance and Secretary
|
|
2006
|
|
$
|
149,573
|
|
|
$
|
23,900
|
|
$
|
4,487
|
|
$
|
1,144
|
(8)
|
|
$
|
179,104
|
|
|
|
|
|
|
|
|
|
Thomas Parr,
Chief Scientific Officer
|
|
2006
|
|
$
|
220,000
|
|
|
$
|
55,000
|
|
$
|
9,242
|
|
$
|
18,275
|
(9)
|
|
$
|
302,517
|
|
|
|
|
Next Section
Previous Section